Documentos relacionados

1. Low-dimensional neural ODEs and their application in pharmacokinetics.
2. [LC-MS quantification and pharmacokinetics of the multi-constituents of Huangqin Tang in rat plasma after different single oral doses].
3. Training the next generation of pharmacometric modelers: a multisector perspective.
4. Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.
5. Properties of the Urothelium that Establish the Blood-Urine Barrier and Their Implications for Drug Delivery.
6. Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation.
7. The Finite Absorption Time (FAT) concept en route to PBPK modeling and pharmacometrics.
8. Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities.
9. Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.
10. Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.